From the Research
To manage Saccharomyces infections effectively, I recommend using liposomal amphotericin B as the primary treatment option, given its high efficacy in driving fungal clearance, as demonstrated in a murine model of disseminated infection 1. When dealing with Saccharomyces lab work, it's essential to consider the potential risks and complications associated with these infections.
- Saccharomyces cerevisiae, commonly known as baker's yeast, can cause invasive infections, particularly in immunocompromised patients, and has been associated with the use of probiotic preparations containing Saccharomyces boulardii 2.
- The treatment of Saccharomyces infections often involves the use of antifungal agents, with liposomal amphotericin B showing the most effective results in a murine model of systemic infection 1.
- Other treatment options, such as voriconazole and anidulafungin, may also be effective, but their efficacy can vary depending on the specific strain and susceptibility of the Saccharomyces isolate 1.
- It's crucial to note that Saccharomyces infections can be clinically indistinguishable from invasive candidiasis, and therefore, a high index of suspicion and appropriate diagnostic testing are necessary for accurate diagnosis 2.
- In addition to antifungal treatment, the removal of central vascular catheters and other potential sources of infection can also be an effective therapeutic strategy 2, 3.
- The use of probiotics containing Saccharomyces boulardii should be approached with caution, particularly in critically ill patients, due to the potential risk of fungemia and other complications 3.